Royal Bank of Canada’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$586K Buy
71,856
+67,651
+1,609% +$552K ﹤0.01% 4030
2025
Q1
$33K Buy
4,205
+2,618
+165% +$20.5K ﹤0.01% 5352
2024
Q4
$24K Sell
1,587
-4,290
-73% -$64.9K ﹤0.01% 5551
2024
Q3
$90K Buy
5,877
+555
+10% +$8.5K ﹤0.01% 4964
2024
Q2
$81K Buy
5,322
+4,117
+342% +$62.7K ﹤0.01% 5009
2024
Q1
$23K Sell
1,205
-4,024
-77% -$76.8K ﹤0.01% 5418
2023
Q4
$100K Buy
5,229
+5,211
+28,950% +$99.7K ﹤0.01% 5090
2023
Q3
$0 Hold
18
﹤0.01% 6907
2023
Q2
$0 Sell
18
-2,969
-99% ﹤0.01% 7044
2023
Q1
$54K Sell
2,987
-16,572
-85% -$300K ﹤0.01% 5204
2022
Q4
$405K Buy
19,559
+4,080
+26% +$84.5K ﹤0.01% 3848
2022
Q3
$404K Buy
15,479
+14,973
+2,959% +$391K ﹤0.01% 3747
2022
Q2
$12K Sell
506
-2,266
-82% -$53.7K ﹤0.01% 5852
2022
Q1
$88K Sell
2,772
-4,743
-63% -$151K ﹤0.01% 5266
2021
Q4
$305K Buy
+7,515
New +$305K ﹤0.01% 4407
2021
Q3
Sell
-3,102
Closed -$85K 7217
2021
Q2
$85K Buy
3,102
+2,124
+217% +$58.2K ﹤0.01% 5233
2021
Q1
$27K Buy
+978
New +$27K ﹤0.01% 5757
2020
Q4
Sell
-73
Closed -$1K 6641
2020
Q3
$1K Sell
73
-16
-18% -$219 ﹤0.01% 5972
2020
Q2
$3K Sell
89
-75
-46% -$2.53K ﹤0.01% 5726
2020
Q1
$2K Sell
164
-3,158
-95% -$38.5K ﹤0.01% 5817
2019
Q4
$33K Buy
3,322
+833
+33% +$8.28K ﹤0.01% 5048
2019
Q3
$23K Buy
2,489
+889
+56% +$8.22K ﹤0.01% 4842
2019
Q2
$13K Buy
1,600
+600
+60% +$4.88K ﹤0.01% 5110
2019
Q1
$12K Hold
1,000
﹤0.01% 5060
2018
Q4
$11K Sell
1,000
-362
-27% -$3.98K ﹤0.01% 5077
2018
Q3
$19K Buy
1,362
+1,342
+6,710% +$18.7K ﹤0.01% 5100
2018
Q2
$0 Buy
+20
New ﹤0.01% 6039